• No results found

Where is the Evidence?

Good support for people with complex needs : What does it look like and where is the evidence?

Good support for people with complex needs : What does it look like and where is the evidence?

... of evidence about the outcomes and costs of models of social care considered good practice for people with complex ...robust evidence of effectiveness related to four different models of organising ...

5

Good support for people with complex needs: What does it look like and where is the evidence?

Good support for people with complex needs: What does it look like and where is the evidence?

... going access to a designated key worker or case manager with specialist knowledge could improve access to, and continuity of, support. Input at this level can be critical to the success of individual care packages, ...

5

The benefits of community participation in rural health
service development: where is the evidence?

The benefits of community participation in rural health service development: where is the evidence?

... This is not an isolated pronouncement. The origins of the concept of community participation in rural health lie in its application by international organisations, such as the World Health Organization, 3 in developing ...

20

Matters Arising: Speciation in stickleback facilitated by admixture – where is the evidence?

Matters Arising: Speciation in stickleback facilitated by admixture – where is the evidence?

... A final issue is that even if we assume that admixture between distinct lineages has occurred in the LC basin, the evidence presented by Marques et al. is insufficient for demonstrating that this has promoted ...

12

High-Protein Weight Loss Diets and Purported Adverse Effects: Where is the Evidence?

High-Protein Weight Loss Diets and Purported Adverse Effects: Where is the Evidence?

... Results of several recent studies show that high-protein, low-carbohydrate weight loss diets indeed have their benefits. However, agencies such as the American Heart Association (AHA) have some concerns about possible ...

7

Treating asthma with omega 3 fatty acids: where is the evidence? A systematic review

Treating asthma with omega 3 fatty acids: where is the evidence? A systematic review

... strategies, evidence rating schemes, and data table design) applied to our respective evidence reports on the health benefits of omega-3 fatty ...Ottawa Evidence-based Practice Center (UO-EPC), this ...

8

Good support for people with complex needs : what does it look like and where is the evidence?

Good support for people with complex needs : what does it look like and where is the evidence?

... School for Social Care Research Improving the evidence base for adult social care practice.. Good social care for people with complex needs.[r] ...

26

Rituximab use in adult primary glomerulopathy: where is the evidence?

Rituximab use in adult primary glomerulopathy: where is the evidence?

... results. Evidence is still lacking for the use of rituximab in patients with immunoglobulin A nephropathy (IgAN) and idiopathic membranoproliferative glomerulonephritis (MPGN), as only few reports used rituximab ...

11

Speciation in stickleback facilitated by admixture where is the evidence?

Speciation in stickleback facilitated by admixture where is the evidence?

... Genetic diversity within populations was quantified based on the haploid individual-level SNP genotype data generated as described for the phylogenetic analysis (minimum leading haplo[r] ...

10

Where is the evidence for emergency planning: a scoping review

Where is the evidence for emergency planning: a scoping review

... retrieve evidence relevant to the whole subject area, subdivided into Business con- tinuity, Hazard analysis, Capability assessment and main- tenance, Recovery, Communications/informatics and Organisational ...

8

CHCHD10 variants in amyotrophic lateral sclerosis: where Is the evidence?

CHCHD10 variants in amyotrophic lateral sclerosis: where Is the evidence?

... 71 Amyotrophic lateral sclerosis ALS; Frontotemperal dementia FTD; minor allele 72 frequency MAF; Sequence kernel association test SKAT; single nucleotide variant 73 SNV; 74 75 Introduct[r] ...

23

Critical care paramedics: Where is the evidence? A systematic review

Critical care paramedics: Where is the evidence? A systematic review

... The applicability of Mabry’s study[31] is limited by its setting within military conflict, however it is the only publication comparing CCP and paramedic care on the same transport platform. The better survival rate in ...

24

Where Is the Second Generation Nowadays? Evidence from Former Transmigration Villages in Jambi Province, Indonesia

Where Is the Second Generation Nowadays? Evidence from Former Transmigration Villages in Jambi Province, Indonesia

... Furthermore, the number of children in family (X8) did not significantly af- fect where the value (p > 0.05) was shown. Therefore, it can be concluded that there was no effect of the number of children in ...

12

Improving corporate governance where the State is the controlling block holder: Evidence from China

Improving corporate governance where the State is the controlling block holder: Evidence from China

... strong evidence that the block transfers between the different ownership categories are true control events, as defined by Barclay and Holderness ...the evidence that the value changes around transfers are ...

61

and where is the body?

and where is the body?

... Of concern for many artists, myself included, is the source of their materials. When learning about wig making, I found that the source of the hair used is almost always presented up front: “made with genuine human ...

55

BoP and MNCs: Where is the Market and Where the Source of Innovation?

BoP and MNCs: Where is the Market and Where the Source of Innovation?

... clear evidence of the fact that rural practices in underdeveloped countries hold a latent potential to benefit the entire world and not just to solve local ...

10

Evidence for oncolytic virotherapy: Where have we got to and where are we going?

Evidence for oncolytic virotherapy: Where have we got to and where are we going?

... era where interest in immune checkpoint inhibitors seems to be increasing exponentially, serious consideration should be given to the consequences of giving an OV in combination with these ...

22

Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand?

Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand?

... Key questions remain unresolved regarding the advantages and limitations of colloids for fluid resuscitation despite extensive investigation. Elucidation of these questions has been slowed, in part, by uncertainty as to ...

5

Where Conversation Analysis meets Language Assessment: Toward expanding epistemologies and validity evidence

Where Conversation Analysis meets Language Assessment: Toward expanding epistemologies and validity evidence

... validity evidence (e.g., evidence of interactional fluency, grammatical complexity) that is gathered needs to differ depending upon the local interactional achievements in each ...accordingly ...

15

Where is Kenya being headed to? Empirical evidence from the Box Jenkins ARIMA approach

Where is Kenya being headed to? Empirical evidence from the Box Jenkins ARIMA approach

... Using annual time series data on GDP per capita in Kenya from 1960 to 2017, the study analyzes GDP per capita using the Box – Jenkins ARIMA technique.. The diagnostic tests such as the A[r] ...

15

Show all 10000 documents...

Related subjects